Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.
作者信息
Providencia Rui
机构信息
University College London, London, United Kingdom
出版信息
N Engl J Med. 2022 Dec 1;387(22):2100. doi: 10.1056/NEJMc2213437.
PMID:36449436
Abstract
摘要
相似文献
1
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.利伐沙班用于风湿性心脏病相关心房颤动
N Engl J Med. 2022 Dec 1;387(22):2100. doi: 10.1056/NEJMc2213437.
2
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.利伐沙班用于风湿性心脏病相关心房颤动
N Engl J Med. 2022 Dec 1;387(22):2100. doi: 10.1056/NEJMc2213437.
3
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. Reply.利伐沙班用于风湿性心脏病相关心房颤动。回复。
N Engl J Med. 2022 Dec 1;387(22):2100-2101. doi: 10.1056/NEJMc2213437.
4
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation.利伐沙班在风湿性心脏病相关心房颤动中的应用。
N Engl J Med. 2022 Sep 15;387(11):978-988. doi: 10.1056/NEJMoa2209051. Epub 2022 Aug 28.
5
Intracardiac Thrombus Following Rivaroxaban Treatment in a Patient with Atrial Fibrillation Associated with Rheumatic Heart Disease.心房颤动合并风湿性心脏病患者应用利伐沙班治疗后出现心腔内血栓。
J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104325. doi: 10.1016/j.jstrokecerebrovasdis.2019.104325. Epub 2019 Aug 16.
6
In rheumatic heart disease-associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 y.在风湿性心脏病相关的心房颤动中，利伐沙班在 3 年时较 VKA 增加了不良血管结局。
Ann Intern Med. 2023 Jan;176(1):JC2. doi: 10.7326/J22-0102. Epub 2023 Jan 3.
7
Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease.心房颤动与风湿性心脏病中的抗凝治疗
N Engl J Med. 2022 Sep 15;387(11):1036-1038. doi: 10.1056/NEJMe2210187. Epub 2022 Aug 28.
8
Management of atrial fibrillation in rheumatic valvular heart disease.风湿性心脏瓣膜病合并心房颤动的管理
Curr Opin Cardiol. 2006 Jan;21(1):47-50. doi: 10.1097/01.hco.0000198985.78508.55.
9
Oral anticoagulation for atrial fibrillation in rheumatic heart disease.风湿性心脏病合并心房颤动的口服抗凝治疗
Eur Heart J. 2023 Jul 14;44(27):2440-2442. doi: 10.1093/eurheartj/ehad390.
10
Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis.利伐沙班在非瓣膜性心房颤动患者真实世界研究中的大出血发生率：一项荟萃分析。
Curr Med Res Opin. 2016 Jun;32(6):1117-20. doi: 10.1185/03007995.2016.1161610. Epub 2016 Mar 16.
Zotero 插件